Effient (prasugrel)

pCPA File Number: 20797

Negotiation Status:

Concluded with an LOI

Indication(s):

Acute Coronary Syndrome

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CDA-AMC Project Number:

SR0263-000

pCPA Engagement Letter Issued:

2012-10-01

Negotiation Process Concluded:

2013-08-07